LumiHeal (K.L) is an early-stage commercial asset (CE mark) with applications in wound care, specifically targeting chronic and complex wounds by providing impact the three (3) critical phases of wound healing: inflammation, proliferation and remodeling. LumiHeal is an active wound care solution that delivers high response rates and ignites the onset of wound regression, while providing an excellent safety profile.
Lumiheal impact the three critical phases of wound healing
FLE stimulates mitochondrial responses and modulates cellular signaling pathways that activate the skin's own repair mechanisms. It specifically targets the three critical phases of wound healing while minimizing pain and bacterial growth.
Changes in wound area during treatment of VLU and DFU
Romanelli M, Piaggesi A, Scapagnini G, et al. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: EUREKA trial. J Wound Care. 2018;27(11):744– 753.https://doi.org/10.12968/jowc.2018.27.11.744